Inflammation-Induced Adverse Pregnancy and Neonatal Outcomes Can Be Improved by the Immunomodulatory Peptide Exendin-4 Article

Garcia-Flores, Valeria, Romero, Roberto, Miller, Derek et al. (2018). Inflammation-Induced Adverse Pregnancy and Neonatal Outcomes Can Be Improved by the Immunomodulatory Peptide Exendin-4 . Frontiers in Immunology, 9 10.3389/fimmu.2018.01291

Open Access International Collaboration

cited authors

  • Garcia-Flores, Valeria; Romero, Roberto; Miller, Derek; Xu, Yi; Done, Bogdan; Veerapaneni, Chharitha; Leng, Yaozhu; Arenas-Hernandez, Marcia; Khan, Nabila; Panaitescu, Bogdan; Hassan, Sonia S; Marat Alvarez-Salas, Luis; Gomez-Lopez, Nardhy

sustainable development goals

authors

publication date

  • June 18, 2018

published in

keywords

  • C-REACTIVE PROTEIN
  • CLINICAL CHORIOAMNIONITIS
  • GLUCAGON-LIKE PEPTIDE-1
  • HISTOLOGIC CHORIOAMNIONITIS
  • HUMAN MONOCYTES/MACROPHAGES
  • INTRA-AMNIOTIC INFECTION
  • INTRAAMNIOTIC INFLAMMATION
  • Immunology
  • Life Sciences & Biomedicine
  • M2 macrophages
  • MICROBIAL INVASION
  • PRETERM PREMATURE RUPTURE
  • REGULATORY T-CELLS
  • Science & Technology
  • amniotic fluid
  • clinical chorioamnionitis
  • fetal inflammatory response syndrome
  • intra-amniotic infection/inflammation
  • neutrophils
  • preterm labor and birth
  • regulatory T cells

Digital Object Identifier (DOI)

volume

  • 9